| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.5394 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.5496 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.5613 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.5629 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.5820 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6400 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6432 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6434 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6510 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6553 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6635 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6749 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6796 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6819 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.6822 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7070 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7126 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7155 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7157 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7213 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7242 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7266 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7301 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7326 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7359 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7427 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7479 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7501 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7628 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7630 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7652 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7659 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7690 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7727 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7749 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7776 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7776 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7859 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.7866 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8102 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8152 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8160 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8160 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8163 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8179 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8193 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8257 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8274 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8278 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8314 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8416 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8497 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8508 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8533 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8538 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8593 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8741 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8891 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8905 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.8965 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9001 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9022 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9128 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9159 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9169 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9177 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9191 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9249 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9317 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9358 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9367 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9428 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9443 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9447 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9455 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9524 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9542 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9583 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9616 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9657 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9701 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9702 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9735 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9782 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9786 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9797 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9815 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9870 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9907 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9909 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9924 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9991 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 0.9993 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0000 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0009 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0071 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0158 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0196 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0202 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0274 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0313 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0334 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0343 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0373 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0413 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0480 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0545 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0707 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0748 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0769 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.0992 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1064 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1115 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1237 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1383 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1389 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1456 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1594 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1715 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1746 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1747 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1891 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.1941 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2037 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2169 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2294 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2339 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2501 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2509 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2583 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2617 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2826 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2882 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2938 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.2979 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3132 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3173 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3313 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3799 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3904 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3941 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.3989 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4159 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4200 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4325 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4479 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4596 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4673 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4837 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4846 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.4966 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.5247 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.5378 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6241 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6287 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6399 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.6769 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.7004 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.7179 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.7202 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.7269 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.7663 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.7857 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.7929 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 1.9968 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.0735 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.1508 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.1670 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.2946 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.2990 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.4127 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.5660 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.6798 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.8376 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 2.9080 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.0130 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.0475 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.0991 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.1391 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.1956 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.2764 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.5951 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.6318 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 3.9766 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 4.0024 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 4.6148 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | N-acetylneuraminate | 5.0109 | scaled units | Low-Dose | +4HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|